Who Paid My Doc
Robert Call
Allergy Richmond, VA Medical Doctor
NPI 1063521904 CMS profile 229880
9920 Independence Park Dr, Suite 100, Richmond, VA 23233
General payments
$1,871,682
Research payments
$320,863
Ownership & investment interest
$2,193,514
Research they led as principal investigator
$33,907,773
Through program year 2024, Robert Call of Richmond, VA is reported in the CMS Open Payments database as having received $1,871,682 across 357 general payments and $320,863 in research payments paid to them. Separately, studies naming them as principal investigator received $33,907,773 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $2,193,514 across 2 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Allergy profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $143 | 3 | |
| 2023 | General | $972 | 40 | |
| 2022 | General | $44,416 | 74 | |
| 2022 | Research | $25,047 | 3 | |
| 2021 | General | $1,426,190 | 92 | |
| 2021 | Research | $5,775 | 4 | |
| 2020 | General | $8,705 | 71 | |
| 2020 | Research | $82,575 | 37 | |
| 2019 | General | $391,257 | 77 | |
| 2019 | Research | $207,467 | 121 | |
| 2020 | Ownership | $846,552 | 1 | |
| 2019 | Ownership | $1,346,962 | 1 |
Beside peers
- Robert Call
- Allergy median
- Middle half of Allergy
- National median
In program year 2025, general payments to Robert Call were reported at $0. Among 526 Allergy profiles paid that year, the median was $1,143 and the middle half received between $226 and $2,504.
Show as a table
| Year | Robert Call | Allergy median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $391,257 | $506 | $151–$1,337 | $163 |
| 2020 | $8,705 | $409 | $108–$1,162 | $114 |
| 2021 | $1,426,190 | $549 | $125–$1,485 | $132 |
| 2022 | $44,416 | $666 | $161–$1,594 | $149 |
| 2023 | $972 | $780 | $186–$1,916 | $160 |
| 2024 | $143 | $1,031 | $271–$2,196 | $164 |
| 2025 | $0 | $1,143 | $226–$2,504 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
24
Drug cost
$170
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 24 | $170 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,579 Part D prescribers listed as Allergy/ Immunology; they describe a distribution and say nothing about conduct.
Records
522 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Allergy in Virginia
Related records
Allergy in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Allergy
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.